Department of Anaesthesiology, Oslo University Hospital Rikshospitalet, Norway.
Acta Anaesthesiol Scand. 2011 Nov;55(10):1196-205. doi: 10.1111/j.1399-6576.2011.02536.x.
Prophylactic dexamethasone, ondansetron and droperidol have a documented effect on post-operative nausea and vomiting (PONV). Still, there is a lack of studies investigating the effect of adding dexamethasone to ondansetron and droperidol in order to treat established PONV.
In this double-blind randomised, controlled trial, we compared triple prophylaxis for PONV consisting of dexamethasone 8 mg intravenous (IV), ondansetron 4 mg IV and droperidol 0.625 mg IV (n = 157) with placebo (n = 156) given before gynaecological day-case surgery. Subsequently, in those having PONV despite triple prophylaxis or placebo, a dose of ondansetron and droperidol plus dexamethasone was compared with the combination of ondansetron and droperidol.
Triple prophylaxis reduced acute PONV (0-6 h) (P = 0.0003) and post-discharge PONV (6-24 h) (P = 0.001) when compared with placebo. Among those suffering from PONV despite placebo or active prophylaxis (n = 80), adding dexamethasone to ondansetron and droperidol reduced acute PONV (0-6 h) (P = 0.025) as well as post-discharge nausea (6-24 h) (P = 0.04) compared with duo treatment comprising ondansetron and droperidol. In those reporting PONV despite prophylaxis (n = 12), the treatment comprising ondansetron and droperidol, with or without dexamethasone, gave a 91.7% reduction in acute PONV and an 83.6% reduction in post-discharge PONV.
Treatment of established PONV comprising ondansetron and droperidol, with or without dexamethasone, reduced PONV in both treatment groups. In those reporting PONV without active prophylaxis, the addition of dexamethasone resulted in a significant amplification of the PONV-reducing [corrected] effects of ondansetron and droperidol.
预防性地使用地塞米松、昂丹司琼和氟哌利多可有效减少术后恶心呕吐(PONV)。然而,目前仍缺乏研究调查在昂丹司琼和氟哌利多的基础上加用地塞米松对已发生的 PONV 的治疗效果。
在这项双盲、随机对照试验中,我们比较了三组预防 PONV 的方案:地塞米松 8mg 静脉注射(IV)、昂丹司琼 4mg IV 和氟哌利多 0.625mg IV(n=157)与安慰剂(n=156)。所有患者均在妇科日间手术后接受预防用药。随后,对于在接受三重预防方案或安慰剂后仍发生 PONV 的患者,我们比较了昂丹司琼和氟哌利多加地塞米松与昂丹司琼和氟哌利多联合方案的疗效。
与安慰剂相比,三重预防方案降低了急性 PONV(0-6h)(P=0.0003)和出院后 PONV(6-24h)(P=0.001)。在那些接受了安慰剂或主动预防治疗但仍发生 PONV 的患者中(n=80),与昂丹司琼和氟哌利多联合治疗相比,添加地塞米松降低了急性 PONV(0-6h)(P=0.025)和出院后恶心(6-24h)(P=0.04)。在那些报告有 PONV 但接受了预防治疗的患者中(n=12),使用昂丹司琼和氟哌利多联合治疗,无论是否添加地塞米松,均可将急性 PONV 的发生率降低 91.7%,将出院后 PONV 的发生率降低 83.6%。
对于已发生的 PONV,使用昂丹司琼和氟哌利多联合治疗,无论是否添加地塞米松,均可降低 PONV 的发生率。在那些没有接受主动预防治疗但报告有 PONV 的患者中,添加地塞米松可显著增强昂丹司琼和氟哌利多的减少 PONV 作用。